Skip to Main Content

Author Details

Kevin Watanabe-Smith
Knight Cancer Institute, Oregon Health & Science University
2010
16
11
PMIDPaper TitleJournal TitlePublished Year
35710794Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.Nat Commun2022
34171263The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.Cancer Cell2021
32315394Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.Blood2020
32754299Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients.Oncotarget2020
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
31784538Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.Nat Commun2019
29567769Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia.Haematologica2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
29572350Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.J Biol Chem2018
28652245Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.Cancer Res2017
28208123Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations.Oncotarget2017
27118405Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.Leukemia2016
25109334Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia.Oncogene2015
24115584Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model.Pediatr Blood Cancer2014
23721813Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice.Stem Cell Res2013
20826722Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.Blood2010
  • 1 - 16 of 16

Recommended Authors

The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 5
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 1
Inner Mongolia University
Career Start Year 2010
Number of shared co-authors 11
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 32
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 5
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Dana Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 2
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 10
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 6
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 1
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 10
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 12
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 1
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 3
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 7
McGill University
Career Start Year 1996
Number of shared co-authors 0
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 5
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 3
The University of Chicago
Career Start Year 1994
Number of shared co-authors 5
Kyoto University
Career Start Year 1993
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 2
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 6
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 9
Benioff Children's Hospitals, University of California san francisco
Career Start Year 1992
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 9

Collaborators

Oregon Health & Science University
Co-authored papers 10
Oregon Health & Science University School of Medicine
Co-authored papers 10
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Oregon Health & Science University, University of California Berkeley
Co-authored papers 7
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Exact Sciences Corporation
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 2
St Jude Children's Research Hospital.
Co-authored papers 2
MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital
Co-authored papers 2
Knight Cardiovascular Institute, Oregon Health and Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
AbbVie Inc.
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
The Ohio State University
Co-authored papers 2
Fred Hutchinson Cancer Research Centre
Co-authored papers 2
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Cancer Early Detection Advanced Research Center, Oregon Health & Science University
Co-authored papers 2
Oregon Health Sciences University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2